Providing an empowering platform for the buyers and sellers of the pharmaceutical supply chain, who aim to expand and identify new business prospects with North American companies and organizations, the world's largest pharmaceutical event series, CPhI, will debut at Pennsylvania Convention Centre, Philadelphia, USA from May 16 to18, 2017.
Over 6,000 potential buyers and partners are expected to attend the event, which will take place on a strategically-zoned show floor, facilitating meetings between the exhibitors and the buyers/partners looking for their products and services. And the organizers are expecting around 630 exhibitors.
The theme for CPhI North America 2017 is “Mix with the world of pharma products, people & solutions.” In short, the mission of CPhI North America is to connect the pharmaceutical industry with solution providers who can help them to address their challenges and take advantage of the opportunities within the industry.
North American market
The launch of CPhI North America has been strategically timed to take advantage of strong industry growth and innovation while addressing the ever-increasing challenges to the future prosperity of the industry. North American pharmaceutical revenue growth is strong, the United States saw an 8.5 per cent growth in 2015.
North America accounting for the largest pharmaceutical market around the globe. .The United States accounts for approximately 40 per cent of the world’s pharmaceutical sales and six of the top 11 companies in the sector are based in the country.
As leaders in pharmaceutical innovation, North American organizations develop a staggering 36per cent of the world’s new molecular entities (NME). With incredible advancements in the understanding of how to treat a wide range of disease states, the pharmaceutical industry now has greater opportunities than ever before.
North America dominated the global $134.2 billion API market in 2015 and is expected to hold its position, owing to the increasing R&D expenditure, rising favourable government initiatives for usage of generic drugs and technological advancements in the field of drug manufacturing. North America has also the largest market share in the pharmaceuticals excipients market.
In North America, approximately 4,100 small molecule drugs are in various stages of development. At the same time nearly 1,000 new large molecule drugs are in various stages of development representing a quarter of all North American drug development activity.
The North American market has a plethora of opportunities for CDMO / CMO companies. In addition, the biopharmaceutical market is growing at an 11 per cent CAGR representing strong future opportunity.
With the North American pharmaceutical market expected to have bright growth prospects upto 2020, there is no better time to introduce the newest edition that caters to the entire supply chain.
While CPhI Worldwide had been held in Europe for many years now, and CPhI holds numerous regional editions around the world, this is the first CPhI North America.
The pharmaceutical industry in North America faces many opportunities, as well as challenges. In terms of opportunities, the release of the Human Genome Project data in 2000 has given us many, many more targets for which to develop drug therapeutics and treat previously untreated diseases. However, R&D productivity in the industry is much lower than it needs to be resulting in the industry being challenged to develop drugs to treat these newly identified genomic targets. Additionally, the industry is facing a great deal of pricing pressures.
However, the industry is facing staggering price control pressures, research and development (R&D) inefficiencies, a need to efficiently manufacture new types of drugs, and mounting regulatory complexity. Industry changes, challenges, and opportunities call for a new event that can help the industry move forward in new ways. CPhI North America has been specifically tailored to meet the requirements of the North American market.
The Connect Conference
Utilizing the strength of the CPhI brand and an adjacency to InformEx, the leading fine and specialty chemical event, CPhI North America will launch the first-ever Connect Conference featuring two educational programs: CPhI Connect, focusing on pharmaceuticals and InformEx Connect, focusing on fine and specialty chemicals.
One of the biggest differences between CPhI North America and other CPhI events is a much more robust conference program. Featuring more than 55 speakers at more than 44 sessions across eight tracks, the Connect Conference will help industry professionals navigate a rapidly evolving regulatory, strategic and technological landscape.
The CPhI and InformEx Connect Conference program will feature more than 44 sessions delivered by more than 55 industry subject matter experts. This conference program is much more robust than the educational programming at any of the other CPhI events.
Powered by the expertise of the American Chemical Society (ACS), the United States Pharmacopeia (USP), the Society of Chemical Manufacturers and Affiliates (SOCMA), and UBM’s rich programming resources, the Connect Conference is unlike any program ever assembled.
CPhI Connect will contain four tracks: Drug Development, Quality/Regulatory, Drug Manufacturing, and Outsourcing. The program will offer perspectives on a wide assortment of pressing topics within the pharmaceutical and biopharmaceutical industries from eminent speakers .
This will be the 33rd edition of InformEx. The adjacency with CPhI North America is expected to tremendously strengthen the event by facilitating the opportunity for both InformEx exhibitors and attendees to connect with a broader cross-section of the pharmaceutical industry. Additionally, the introduction of the InformEx Connect Conference is very new.
InformEx Connect will contain four tracks: The Business of Chemicals, AgroChem Spotlight, Regulatory Spotlight, and ChemInnovation. The program will offer perspectives on a wide assortment of pressing topics within the specialty chemicals industry from eminent speakers.
ICSE (an event connecting the pharmaceutical community with outsourcing solution providers) and InnoPack (an event at which innovative drug delivery solutions will be provided to satisfy the changing way in which medication is packaged and delivered) are the other events co-located with the first edition of CPhI North America
Highlights of the event
Highlights and event features of CPhI North America and InformEx 2017 include:.
Innovation Forward Exhibition - containing more than 630 exhibitors. The exhibition floor is zoned to help attendees to more seamlessly build their experience. Exhibition floor zones will include:
InformEx: This innovation-focused show is aimed at building a global network of customers, suppliers, and colleagues in some of the most rapidly growing chemical markets, including medical devices, agrochemistry, biopharma, and green chemistry.
iCSE: The Drug Development Zone will highlight world-class CROs and other organizations serving drug developers.
CPhI: The Manufacturing Ingredients Zone will consist of active product ingredients (API) and excipient leaders.
FDF: The Finished Drug Products Zone will feature leading small- and large-molecule CDMO/CMOs.
InnoPack: The Packaging Zone will showcase packaging innovation.
BOND Exclusive Meeting Service - a high-value opportunity to make connections based on compatible needs and capabilities facilitated by the BOND meeting service program.
CPhI Online and on-site Supplier Finder kiosks - extremely helpful tools as attendees seeks specific solutions
Women in Leadership Forum – The Women in Leadership Forum is designed to advance women in science through skill development and networking.
Insight Briefings - Will include in-depth seminars on technical and business topics right on the CPhI North America exhibition floor, accessible to all exhibition visitors. Topics include accelerated drug approval programs, the digital transformation of the pharmaceutical industry, supply chain security advancements and much more.
Exhibitor Showcases - platform for pharma professionals to present forward-thinking perspectives on their key products, innovations and services. These 25 minute free-to-attend presentations provide an open platform to interact face-to-face with developers.
The exhibition floor and networking opportunities, including the BOND meeting service, will help the industry to make connections that will allow them to collaborate and solve their challenges.
The expected attendees are having a variety of titles and functions within the pharmaceutical and specialty chemicals industries including: C-level executives (CEO, COOs), R&D, manufacturing, quality and regulatory executives, supply chain, packaging and procurement. Vice presidents, directors, managers and individual contributors within each of these areas will also be in attendance.
Exhibitors on the show floor will include: manufacturers, distributors, & service providers to the global fine and specialty chemical industry, contract research organizations (CRO), pharmaceutical excipient, API and other raw material manufacturers, equipment, and contract development and manufacturing organizations (CDMO) for the creation of finished drugs, packaging materials, technologies and equipment, biopharmaceutical technologies and suppliers and much more.
As a marketplace, CPhI North America is designed to bring key business leaders together under one roof, with the objective of fostering dynamic business relationships. Since it is the show’s inaugural essay in the region, it will be the epicentre for innovation, emerging trends, insights and education. It is expected to bring the entire pharmaceutical ecosystem - from early discovery to commercialisation - together under one roof, offering access to the right partners at every stage of development.